ST. PAUL, Minn., Aug. 11, 2026 (GLOBE NEWSWIRE) -- Egg Medical announced today that Rampart IC, LLC (“Rampart”) withdrew its appeal of the USPTO’s reexamination decision that the claims of Rampart’s U.S. Patent No. 11, 660,056 as originally granted were invalid. The USPTO’s invalidation is based on grounds that the inventions in the issued ‘056 Patent were either previously invented by, or simply obvious variants of work, by others, including Egg Medical.

The claims that are likely to survive the reexamination resulted from Rampart making material limitations to the originally issued claims, thus narrowing the ‘056 Patent.

The reexamination of the ‘056 Patent was requested by Egg Medical after Rampart sued Egg Medical for infringement of the original ‘056 Patent in U.S. District Court. Egg Medical has not sought conflict with Rampart. However, in light of Rampart’s actions, Egg Medical has given notice of its earlier patent and demanded that Rampart cease and desist its infringing activities of Egg Medical’s patent.

Egg Medical Chief Executive Officer, Robert Wilson commented, “Protection of inventorship is important. We thank the Patent Office for a comprehensive re-examination of the Rampart patent. The invalidation of the original ‘056 Patent claims and the possible issuance of narrowed claims that do not cover any of our product line reinforces the integrity of the US patent system.”

Gavin Philips, Egg Medical’s Chief Commercial Officer added, “Egg Medical will continue to invest in what really matters to our customers, namely, the technology that has defined the Enhanced Radiation Protection Device category: whole-room, scatter reduction that protects the entire procedural team without construction, without rolling trip-hazards, or workflow interruptions.”

About Egg Medical

Egg Medical is a global leader in radiation protection, founded with the goal of reducing the radiation exposure of healthcare workers who use x-ray imaging to perform life-saving diagnostic and therapeutic procedures for patients.

Media Contact:

Susan Storm, sstorm@eggmedical.com

This item of content is a press release from a third party provider who make no warranties or representations in connection with this content and therefore PA can make no warranties in respect of its use.

Tags

More Like This

Egg Medical Presents CRT 2026 Data Demonstrating a Responsible Path to Light Lead and Lead-Apron Free Protection

Egg Medical Declares New Era in Fluoroscopy Lab Safety Following Joint Consensus Statement

Egg Medical Launches EggNest™ Complete Flex: Apron-Free Protection Without Construction, Downtime or Disruption

United States Patent and Trademark Office (USPTO) Cancels All Claims of Swift Medical's Patent

Diamyd Medical receives Notice of Allowance for key retogatein US patent

Hologic Secures Significant Patent Victory Against Siemens Over Breast Cancer Detection Technology

KUVINGS SECURES NON-INFRINGEMENT RULING FOR AUTO10 AT UPC COURT OF APPEAL; SALES RESTRICTIONS LIFTED ACROSS EUROPE

US International Trade Commission's (US ITC) determination confirmed, banning Innoscience's patent-infringing GaN products from U.S. market